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At present, there is an unprecedented level of interest in the properties and structures of
complexes consisting of DNA mixed with oppositely charged cationic liposomes (CLs).
The interest arises because the complexes mimic natural viruses as chemical carriers of
DNA into cells in worldwide human gene therapy clinical trials. However, since our
understanding of the mechanisms of action of CL–DNA complexes interacting with cells
remains poor, signiﬁcant additional insights and discoveries will be required before the
development of efﬁcient chemical carriers suitable for long-term therapeutic applications.
Recent studies describe synchrotron X-ray diffraction, which has revealed the liquid
crystalline nature of CL–DNA complexes, and three-dimensional laser-scanning confocal
microscopy, which reveals CL–DNA pathways and interactions with cells. The
importance of the liquid crystalline structures in biological function is revealed in the
application of these modern techniques in combination with functional transfection
efﬁciency measurements, which shows that the mechanism of gene release from
complexes in the cell cytoplasm is dependent on their precise liquid crystalline nature
and the physical and chemical parameters (for example, the membrane charge density)
of the complexes. In §5, we describe some recent new results aimed at developing
bionanotube vectors for gene delivery.
Keywords: cationic liposomes; liquid crystal phases; gene therapy; gene delivery;
synchrotron X-ray scattering; transfection efﬁciency
1. Introduction
The subﬁeld of gene therapy focusing on developing synthetic vectors
(carriers) intended for therapeutic applications, in particular, using cationic
liposomes (CLs; closed lipid bilayer membrane shells shown in the blow-up in
ﬁgure 1) as carriers, has recently fundergone a renaissance (Friedmann 1997;
Rinehart et al. 1997; Miller 1998, 2003; Stopeck et al. 1998; Clark & Hersh
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Ferber 2001; Henry 2001; Niidome & Huang 2002; Mahato & Kim 2002;
Saﬁnya et al. 2002; Ewert et al. 2004, 2005a,b; Saﬁnya 2001, 2004). To a large
extent, this is owing to the non-immunogenicity of synthetic vectors. In
addition, with recent technology, the possibility of developing human artiﬁcial
chromosomes (HACs) containing multiple genes and regulatory constructs for
gene therapy applications requires the simultaneous development of the
appropriate synthetic carriers for transfer in mammalian cells (Harrington
et al. 1997; Willard 2000). However, transfection efﬁciency (TE; a measure of
the amount of exogenous DNA transferred into cells followed by gene
expression) remains low compared to engineered viral vectors and only a
comprehensive knowledge of the interactions between CL–DNA complexes and
cells will result in optimization of TE. The long-term objective of research in
this area is to develop a fundamental science base, which will lead to a
predictive mode for the design and synthesis of optimal synthetic carriers of
DNA for gene therapy and disease control.
The ﬁrst application of CLs as gene vectors resulted from a landmark study by
Phillip Felgner and collaborators (Felgner et al. 1987; Felgner & Rhodes 1991) and
was rapidly followed by numerous pioneering studies by Leaf Huang, which
continue to date (Wolff 1994; Huang et al. 1999, 2005; Chesnoy & Huang 2000;
Niidome&Huang2002).Theoriginalideashownschematicallyinﬁgure1wasthat
positively charged CL–DNA complexes (with the number of cationic charges from
the lipid exceeding the number of negative phosphate groups from DNA) should
bind electrostatically to mammalian cells, which contain surface proteoglycans
with negatively charged sulphated groups (Mislick & Baldeschwieler 1996;
DNA
CL
Figure 1. Cartoon of a ‘beads-on-a-string’ (i.e. CLs attached to a string of DNA) complex
electrostatically bound to the surface of an animal cell. The blow-up shows a CL electrostatically
binding a section of negatively charged DNA on one side and the plasma membrane containing
cell surface proteoglycans with negatively charged sulphated groups on the other side. X-ray
diffraction studies have shown that the equilibrium phases of mixtures of CLs and DNA are
composed of higher ordered self-assembled liquid crystalline structures, two of which are depicted
in ﬁgures 2 and 8.
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enhancement in cell transfection compared to previous experiments with other
synthetic methods led to early clinical trials using CL vectors by Gary and
Elizabeth Nabel (Nabel et al. 1993), Evan Hersh and collaborators (Rinehart et al.
1997; Stopeck et al. 1998; Clark & Hersh 1999) and numerous other groups.
Presently, more than 20% of the ongoing worldwide human gene therapy clinical
trials use synthetic vectors with CL carriers employed in about one-third of those
trials (Edelstein et al. 2004).
RecentsynchrotronX-raydiffractionworkhasrevealedthatuponmixing,under
equilibrium conditions, CLs (approx. 50–100 nm diameter) and DNA spon-
taneously self-assemble into novel liquid crystalline phases. Indeed, the beads
(CLs)-on-a-string (DNA) model is not observed experimentally. In particular,
X-ray studies have led to models of two types of structures observed in CL–DNA
complexes.Theseincludeamultilamellarstructure(labelledLC
a),showninﬁgure2,
with DNA monolayers sandwiched between cationic membranes (Lasic et al. 1997;
Ra ¨dler et al. 1997, 1998; Salditt et al. 1997, 1998; Koltover et al. 1999, 2000) and an
invertedhexagonalstructurewithDNAencapsulatedwithintheinversecylindrical
micelles (HC
II; Koltover et al. 1998). Statistical mechanical models have shown that
theself-assembledliquidcrystallineLC
a andHC
II phasesobservedexperimentallyare
indeed equilibrium phases of CL–DNA complexes (Bruinsma 1998; Harries et al.
1998; May & Ben-Shaul 2004).
In this paper, we will describe recent work that begins the process of
elucidating the relationship between the chemical–physical properties of
CL–DNA complexes with well-deﬁned structures (e.g. the membrane charge
density and the curvature elastic moduli) and TE in mammalian cells. To
achieve these goals, we have used synchrotron X-ray diffraction for structure
determination (Ra ¨dler et al. 1997; Salditt et al. 1997; Koltover et al. 1998; Lin
et al. 2003), three-dimensional laser-scanning confocal microscopy (LSCM) to
image complex pathways and interactions with cells (Lin et al. 2000, 2003) and
reporter gene assays to determine TE (Ewert et al. 2002; Lin et al. 2003; Ahmad
et al. 2005). The combination of these three characterization methods allows us
to rationalize different interactions, observed in confocal microscopy, between
high and low TE complexes and cells, based on the knowledge of the structure of
the complex. For the lamellar LC
a complexes, the data lead to a model with
distinct cell transfection regimes for gene delivery as a function of the membrane
charge density (Lin et al. 2003; Ahmad et al. 2005). It is found that the TE
behaviour of the inverted hexagonal HC
II CL–DNA complexes is independent of
the membrane charge density.
All the present methods of gene delivery involve starting with a vector (either
an engineered virus or a synthetic carrier), which contains the therapeutic gene
followed by either ex vivo or in vivo transfer methods (Friedmann 1997). In the
ex vivo method, the vectors mix with and transfect the human cells derived from
patient tissue, which are then returned to the patient. The in vivo method may
involve either systemic delivery, for example, with an injection, or local
injections into tumours. In the latter case, most of the current clinical trials
are aimed at delivering genes, which encode for cytokines (which are immune
cell-signalling molecules), and are expected to result in an immune assault on the
tumour (Rinehart et al. 1997; Stopeck et al. 1998; Clark & Hersh 1999).
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replication-deﬁcient engineered viruses, which include retroviruses (which
integrate within the host chromosome and may offer a permanent cure) and
adenoviruses (which do not integrate in the host chromosome and act transiently)
among others (Friedmann 1997). Synthetic vectors include carriers consisting of
lipids, polymers, designed macromolecules and peptides, or their combinations
(Huang et al. 1999, 2005; Mahato & Kim 2002; Miller 2003; Saﬁnya 2004).
The main advantage of viral-based vectors is that they have evolved over
millions of years to deliver their genome nearly perfectly to their host cells. The
viral methods, which started the entire ﬁeld of gene therapy more than two
decades ago, are of course immensely important owing to their extreme high
efﬁciency. However, on occasion, they have also led to undesirable side effects.
These include a reported unfortunate death owing to a severe immune response
in a trial with engineered adenoviruses (Marshall 2002; Raper et al. 2003) and the
recent ﬁnding of the risk of insertional oncogenesis (incorrect insertion of the
therapeutic gene within the regulatory or gene regions of a host genome leading
to cancer), where two out of ten children developed leukaemia in a trial to correct
X-linked severe combined immunodeﬁciency with an engineered retrovirus
vector (Cavazzana-Calvo et al.2 0 0 0 ; Hacein-Bey-Abina et al.2 0 0 3 a,b;
Williams & Baum 2003).
The main problem with synthetic vectors is that they are not yet efﬁcient
transfection agents and much more future research and development will be
required before their efﬁciency becomes competitive with viral vectors. On the
other hand, they are relatively safe. As mentioned previously, a signiﬁcant
advantage of synthetic vectors is that there is no size limit to the piece of DNA
carried by them inside the cells. This was convincingly demonstrated when
Willard and Harrington (Harrington et al. 1997; Roush 1997; Willard 2000)
developed the ﬁrst HACs, which range in size between six million and ten
dw
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Figure 2. The lamellar LC
a phase of CL–DNA complexes with alternating lipid bilayer and DNA
monolayer. The LC
a phase is one of the several possible equilibrium phases, which is formed when
CLs are mixed with DNA. Redrawn from Ra ¨dler et al. (1997).
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(In comparison, viral vectors have a maximum carrying capacity of about 40 000
base pairs. Many important human genes extend over more than 40 000 base
pairs, if their regulatory sequences and the non-coding intron regions separating
the coding exon sequences are included.) This landmark achievement used CLs
as carriers of the HACs into mammalian cells. One can expect that in the future,
entire cassettes of genes and regulatory sequences spanning millions of base pairs
will be simultaneously delivered for therapeutic applications using synthetic
carriers complexed with designer HACs.
The remainder of this paper is organized as follows. After a brief description of
the materials in §2, two well-known equilibrium structures of CL–DNA
complexes are described in §3. This is followed by a description on the relation
between structure and function of CL–DNA complexes and the introduction of
some models of cell transfection in §4. Section 5 provides a summary and an
outline of future directions in research and development in the vibrant ﬁeld of
synthetic gene delivery. In particular, the section describes the recent work in a
new direction focused on developing bionanotubes for gene delivery (Raviv et al.
2005). A more detailed accounting of reviews of our group’s research (some of
which are described in this paper) may be found elsewhere (Saﬁnya 2001; Saﬁnya
et al. 2002; Ewert et al. 2004, 2005a,b).
2. Materials
Selection of lipids used in the studies is shown in ﬁgure 4. The charged lipids
consisted of univalent cationic dioleoyltrimethylammonium propane (DOTAP)
and N-(2-hydroxyethyl)-N,N-dimethyl-2,3-bis(tetradecyloxy)-1-propanaminium
(DMRIE), multivalent cationic lipid 2,3-dioleyloxy-N-(2-(sperminecarboxamido)
ethyl)-N,N-dimethyl-1-propaniminium penta-hydrochloride (DOSPA) supplied
by P. Felgner (then at Vical, Inc.), and a series of custom-synthesized multivalent
Figure 3. Arrow points to a human artiﬁcial chromosome among several normal chromosomes.
Adapted from Harrington et al. (1997).
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consisted of either dioleoyl-phosphatidyl cholin (DOPC)or dioleoyl-phosphatidyl-
ethanolamine (DOPE).
The linear DNA consisted of lambda-phage DNA (48 502 bp, contour lengthZ
16.5 mm). Circular plasmid DNA containing the luciferase gene and SV40
promoter/enhancer elements was used for the functional studies (pGL3-control
vector, Promega Corporation, Cat. no. E1741). The enzyme luciferase catalyses
light production (around 560 nm) in bioluminescent organisms, such as the
ﬁreﬂy, jellyﬁsh and some bacteria. The gene from the North American ﬁreﬂy
(Photinus pyralis) was used for this work. Mouse ﬁbroblast L cell lines were used
in the TE studies. The details of the materials and methods are published
elsewhere (Koltover et al. 1999, 2000; Lin et al. 2000, 2003; Ewert et al. 2002,
2005a,b; Ahmad et al. 2005).
3. Equilibrium structures of cationic liposome–DNA complexes
The mixture of CLs (with an average diameter of approximately 50 nm) with a
solution of DNA results in CL–DNA complexes, which are readily observable as
well-deﬁned globules using differential interference contrast (DIC) optical
microscopy. A series of such images are shown in the micrographs of ﬁgure 5 for
different weight ratios of total lipid to DNA (L/D). The liposomes consisted of a
50/50 wt% mixture of cationic DOTAP and DOPC. The isoelectric point of the
CL–DNA complexes occurs at L/DZ4.4 for this mixture. At L/Dz5, the
complexes are nearly neutral in charge, and upon colliding, the globules tend to
stick owing to the van der Waals attraction leading to large aggregates of globules
(ﬁgure 5c). Polarized microscopy reveals that these aggregates are optically
birefringent, which is consistent with their liquid crystalline nature revealed by
X-ray diffraction. At L/Dz2( ﬁgure 5d), the complexes are negative and the
aggregatedglobulesdissociateowingtoelectrostaticrepulsions.Ontheothersideof
the isoelectric point at L/Dz10 and 50 (ﬁgure 5a,b), the complexes are positively
charged and once again the globules tend to repel each other upon approach owing
to the electrostatic repulsions.
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Figure 4. Some lipids used in the structure and function studies of CL–DNA complexes.
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complexes at the angstrom scale. Figure 6 shows synchrotron X-ray diffraction
data (taken at the Stanford Synchrotron Radiation Laboratory) of CL–DNA
complexes at the isoelectric point (DOTAP/DNAZ2.2, wt/wt) for CLs consisting
of a mixture of DOTAP and DOPC (DOPC/DOTAPZ2.2, wt/wt). The sharp
00L peaks, which include the 001 and 002, are visible in this q-range. The 003
is absent owing to the form factor and several higher order peaks (not shown)
are visible up to 005. The 00L peaks result from the layered structure of the
lamellarLC
a phase of CL–DNAcomplexes shown in ﬁgure2 with dZ2p/q001ZdmC
dwZ64 A ˚. dmZ39 A ˚ is the membrane thickness, which can be measured with
X-ray diffraction of the multilamellar lipids in the absence of DNA. The remaining
water layer thickness dwZdKdmZ25 A ˚ is the thickness required to allow a
monolayer of DNA in its hydrated B-form sandwiched between the lipid bilayers
as shown in ﬁgure 2. The broad peak visible between the 001 and 002 corresponds
to the DNA–DNA correlation peak and gives an average DNA inter-helical
distance of dDNAZ2p/qDNAZ47.5 A ˚ for the sample preparation of isoelectric
complexes with L/DZ7. As previously described (Ra ¨dler et al. 1997; Salditt et al.
1997; Koltover et al. 1999, 2000), the sandwiched DNA forms a one-dimensional
array of chains, which uniformly cover the available lipid area and dDNA is a simple
function of L/D and may range from approximately 25 A ˚ (L/DZ2.2) at high
membrane charge densities, where the DNA rods are nearly touching, to as large
as about 55 A ˚ (L/Dz9) at low membrane charge densities. The lamellar LC
a phase
of CL–DNA complexes is a novel hybrid liquid crystalline phase: the lipids form a
three-dimensional smectic phase, while the DNA rods between the lipid bilayers
form a two-dimensional smectic phase.
The spontaneous self-assembly of CLs and DNA into the lamellar LC
a phase
shown in ﬁgure 2 may be understood as follows. In solution, the bare length (lo)
betweennegativephosphategroupsontheDNAbackboneisequalto1.7 A ˚,whichis
L/D ≈ 5
L/D ≈ 2
L/D ≈ 50 L/D ≈ 10
Figure 5. DIC optical micrographs of CL–DNA complexes at different ratios of lipid to DNA (L/D)
weight ratios. For L/DO4.4, the globules are positively charged, and for L/D!4.4, the globules
are negatively charged. The formation of well-deﬁned globules upon mixing CLs with DNA is
readily observable. Scale bar, 10 mm. Adapted from Ra ¨dler et al. (1997).
2579 Cationic liposome–DNA complexes
Phil. Trans. R. Soc. A (2006)less than the Bjerrum length in water, lB (he
2/3wkBT)Z7.1 A ˚ (the dielectric
constant 3wZ80). (The Bjerrum length corresponds to the distance where the
Coulomb energy between two unit charges is equal to the thermal energy kBT.)
Under these conditions, a mean-ﬁeld nonlinear Poisson–Boltzmann analysis shows
that positive counter-ions will condense on the DNA backbone until the Manning
parameter xZlB=l 
o approaches 1 (Manning 1978). Here, l 
o is the renormalized
distancebetweennegativechargesaftercounter-ioncondensation.Thecounter-ion
condensation on the DNA backbone is shown schematically in ﬁgure 7 (top left).
A similar analysis shown schematically in ﬁgure 7 (top right) shows that
near the surface of a positively charged membrane (i.e. the CL surface), nearly
half of the negative counter-ions are present within the Gouy–Chapman length
lG–Che/2plBs (s is the charge per unit area of the membrane; Le Bret & Zimm
1984). Through DNA–lipid condensation, the cationic lipid tends to completely
neutralize the phosphate groups on the DNA in effect replacing and releasing the
originally condensed counter-ions in solution (ﬁgure 7, bottom). Thus, the
driving force for higher order self-assembly into the lamellar LC
a phase is the
entropy gain through the release of counter-ions, which were one-dimensionally
bound to DNA and two-dimensionally bound to cationic membranes, into
solution (Ra ¨dler et al. 1997). We point out that we are using the word ‘bound
counter-ions’ in a very loose form: the bound counter-ions near the
macromolecular surfaces are nevertheless in a completely hydrated state and
so there is no change in the entropy of water molecules when ‘bound counter-
ions’ are released into solution.
In contrast to the so far discussed neutral lipid DOPC, which confers a zero
spontaneous curvature to membranes, another commonly used neutral lipid in
CL–DNA mixtures is DOPE. It is well known that DOPE is a cone-shaped lipid,
which confers a negative curvature to membranes. Synchrotron X-ray diffraction
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Figure 6. SynchrotronX-raydiffractionpatternofCL–DNAcomplexes,wherethemembranesconsist
of mixtures of cationic DOTAP and the charge neutral lipid DOPC (with a zero spontaneous
curvature) with DOTAP/DNAZ2.2 (wt/wt, isoelectric complexes) and DOPC/DOTAPZ2.2
(wt/wt). As described in the text, this diffraction pattern is consistent with the angstrom scale model
of the LC
a phase of CL–DNA complexes shown in ﬁgure 2. Adapted from Ra ¨dler et al. (1997).
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with DNA, may give rise to a completely different columnar inverted hexagonal
HC
II liquid crystalline structure shown in ﬁgure 8, when the weight fraction of
DOPE (FDOPEhweightDOPE/(weightDOPECweightDOTAP)) is greater than
approximately 0.65 (Koltover et al. 1998; Lin et al. 2003). The HC
II phase
consists of an inverted hexagonal structure, where the DNA molecules are
inserted in tubes composed of inverse lipid micelles and assembled on a
hexagonal lattice. The structure resembles the inverted hexagonal HII phase
of DOPE in excess water (Seddon 1990), with the space inside the micelle ﬁlled
by DNA.
We can understand the LC
a to HC
II transition as a function of increasing FDOPE by
noting that the spontaneous curvature of the monolayer mixture of DOTAP and
DOPE is driven negative with the addition of DOPE:CoZ1=RoZFDOPECDOPE
o .
Hence, as FDOPE increases, we expect a transition from the LC
a to the HC
II phase,
which is observed experimentally and is favoured by the elastic free energy. Thus,
the lipid DOPE induces the LC
a to HC
II transition by controlling the spontaneous
curvature of the membranes.
4. Structure–function studies
A major goal in the ﬁeld of gene delivery with synthetic vectors is the elucidation
of the relationship between the structure and the physical–chemical properties of
CL–DNA complexes, and their TE (i.e. the function of the complex). For
example, it had been known empirically that TE in mammalian cells is
signiﬁcantly higher in CL–DNA complexes, which contain about 70 wt% neutral
DNA + membrane
lo*= lB
lo< l B= 7.1 Å
lo lG– C
Figure 7. Both DNA and cationic membranes of liposomes (top) have counter-ions ‘loosely’ bound
in the vicinity of their surfaces as described in the text. The DNA–lipid condensation (bottom),
which occurs during the formation of the LC
a phase of CL–DNA complexes can occur as a result of
the release of ‘bound’ counter-ions in solution with a corresponding gain in entropy.
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diffraction shows that DOTAP containing complexes with 70% DOPE are
typically in the HC
II phase (Koltover et al. 1998; Lin et al. 2003). This raises the
question of why does the HC
II phase transfect better than the LC
a phase? The
answer is rather subtle: while it is true that CLs with 70% DOPE transfect
signiﬁcantly better than CLs with 70% DOPC (for complexes with univalent
cationic lipids), in fact, as we show subsequently, one may design lamellar LC
a
complexes, which are as transfecting as HC
II complexes (Ewert et al. 2002; Lin
et al. 2003; Ahmad et al. 2005).
LSCM has been used to shed light on structure–function correlations by
directly visualizing, in three dimensions, CL–DNA complexes interacting with
cells (Lin et al. 2003). LSCM provides a spatial resolution of about 300 nm in the
x- and y-directions and 800 nm in the z-directions, and allows an unprecedented
insight into the mechanisms by which the liquid crystalline complexes enter cells
and the conditions that lead to the subsequent release of their cargo DNA
molecules. In the experiments, the lipids were labelled with 0.2 wt% Texas Red
1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine, triethylammonium salt
(DHPE) from Molecular Probes, Inc., which emits red ﬂuorescence at 583 nm,
and the DNA was covalently labelled with Mirus Label IT using the PanVera
Corporation protocol, which emits green ﬂuorescence at 492 nm. Thus, an intact
complex appears yellow.
Figure 9 shows a representative confocal image of a ﬁxed mouse ﬁbroblast
L-cell transfected with HC
II complexes at FDOPEZ0.69. (The complexes were
allowed to incubate with the cell for 6 h before cell ﬁxation was performed.) The
ﬁgure shows images from three relevant planes (x–y, y–z and x–z), which allows
one to track the position of the objects within the cell. The lipid ﬂuorescence
clearly outlines the plasma membrane, indicating either spontaneous transfer of
labelled lipid or fusion of lipids from the membranes of the complex with the
plasma membrane before or after entry through the endocytic pathway.
HII
C
Figure 8. The inverted hexagonal HC
II liquid crystalline phase of CL–DNA complexes with DNA
chains coated with inverse micelles arranged on a hexagonal lattice. The HC
II is one of the several
possible equilibrium phases of CL–DNA complexes. Adapted from Koltover et al. (1998).
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The simplest interpretation of the image is that the interaction between HC
II
complexes and cells leads to lipid fusion events, which aid in the dissociation and
release of DNA from the CL vector. This is also consistent with the known high
TE of HC
II CL–DNA complexes (Lin et al. 2003).
Figure 10 shows similar confocal images of mouse L-cells taken 6 h after
incubationwithLC
a complexesatFDOPCZ0.67toallowoptimaltransfection.When
comparingto ﬁgure9 showingthe interactionof HC
II complexeswith cells, we see no
evidence of lipid-free DNA (green), but instead intact CL–DNA complexes are
observed inside cells. (Other x–y planes at different z-positions, not shown here,
show the presence of many yellow complexes and no free DNA.) From the image,
whichdoesnotdisplayanyevidenceoffusionwiththeplasmamembrane,itisclear
thatLC
a complexesentercellsthroughendocytosis.Furthermore,whenendocytosis
is inhibited by preparing cells at 48C, no complexes are observed inside cells and all
remain attached to the cell surface. This observation is consistent with the work of
other groups (Wrobel & Collins 1995). Using the reagent chloroquine (which
disrupts endosomes), it has been shown that the intact CL–DNA complexes
observed in ﬁgure 10 are typically trapped within the endosomes (Lin et al. 2003).
Thus, together with the chloroquine experiments, the confocal image suggests that
at FDOPCZ0.67, most of the DNA remains trapped by the CL vector within
endosomes consistent with the measured low TE.
y
z
y
x
x
z
Figure 9. Laser scanning confocal microscopic image of HC
II CL–DNA complexes interacting with a
mouse ﬁbroblast cell and ﬁxed after 6 h (69 wt% DOPE/31 wt% DOTAP, DOTAP/DNA charge
ratioZ2.8). DNA is labelled green and lipid is labelled red. The plasma membrane is seen to be red,
which indicates either a direct or indirect fusion event (during endocytosis) with the membrane of
complexes as described in the text. The circle in the x–y plane identiﬁes a condensed DNA globule,
which can also be seen in the x–z and y–z planes (arrows). Adapted from Lin et al. (2003).
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a CL–DNA complexes
containing DOPC, an initial study was carried out as a function of mole fractions
of DOPC in three commonly available cationic lipids: univalent DOTAP,
DMRIE and the multivalent DOSPA (5
C). The data in ﬁgure 11a show the
increase in TE of DOPC/DOTAP–DNA complexes (red diamonds), which is
very low at 0.5!FDOPC!0.7 and increases substantially in two decades to
FDOPCZ0.2, similar to TE of HC
II DOPE/DOTAP–DNA complexes. Similar
results were obtained for another univalent cationic lipid DMRIE (black
triangles). The multivalent cationic lipid DOSPA (blue squares) exhibited
strikingly different behaviour, where it was observed that DOSPA containing
complexes remained highly transfectant at much larger mole fractions of DOPC,
even as large as 0.7 (the point at which the univalent cationic lipids exhibit TE
lower in nearly two decades).
The main difference between the cationic lipids is the much higher charge
density of DOSPA (see ﬁgure 4), with a larger headgroup carrying potentially up
to ﬁve cationic charges. This implies that for a given FDOPC, the membrane
charge density (sM, cationic charge per unit area) is signiﬁcantly higher in
DOSPA compared to DOTAP- or DMRIE-containing complexes. The same TE
data are plotted in ﬁgure 11b, but now versus sM,
sM h½1KFnl=ðFnl CrFclÞ scl: ð4:1Þ
y
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Figure 10. Laser-scanning confocal microscopic image of LC
a CL–DNA complexes interacting with a
mouse ﬁbroblast L-cell and ﬁxed after 6 h (67 wt% DOPC/33 wt% DOTAP, DOTAP/DNA charge
ratioZ2.8). DNA is labelled green and lipid is labelled red. In contrast to ﬁgure 9, no fusion with
the plasma membrane is seen. Inside the cell, only intact complexes (yellow) are found (circle in
x–y plane and corresponding arrows in the x–z and y–z planes). This indicates that for the high
weight fraction (0.67) of the neutral lipid DOPC, the CL vector does not release DNA consistent
with the observed low TE. Adapted from Lin et al. (2003).
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sclZeZ/Acl the charge density of the cationic lipid with valence Z, and FnlZNnl/
(NnlCNcl) and FclZNcl/(NnlCNcl) the mole fractions of the neutral and cationic
lipids, respectively. From the data in ﬁgure 11b, AnlZ70 A ˚2, rDOTAPZrDMRIEZ1,
rDOSPAZ2, ZDOTAPZZDMRIEZ1 and ZDOSPAZ3( Lin et al. 2003).
The data, which are widely spread when plotted as a function of the mole
fraction of the neutral lipid (ﬁgure 11a), collapse onto a universal curve as a
function of sM with TE varying over nearly four decades, while sM increases by
only a factor of approximately 8 (sM between 0.0015 and 0.012 e A ˚K2). Thus,
even though the CL–DNA cell system is very complex, the data show that sM is a
universal parameter for transfection with lamellar LC
a CL vectors.
To further study the dependence of TE on sM and access even higher charge
densities (compared to the data of ﬁgure 11), a novel set of multivalent lipids
(MVLs) were synthesized, which allows systematic variation of headgroup size
and charge (Ewert et al. 2002; Ahmad et al. 2005). Figure 12 shows the chemical
structure and maximum charge of the MVLs used in this study (Ewert et al.
2002; Ahmad et al. 2005).
X-ray diffraction shows that the MVLs shown in ﬁgure 12 form DNA
complexes that exhibit the lamellar (LC
a) phase, the more prevalent of the two
known complex structures. Figure 13 shows the TE data plotted versus the
membrane charge density for four of the MVL–DNA complexes with charge
variation between 2
C and 5
C. To calculate sm, equation (4.1) was used with
109
108
107
106
105
104
t
r
a
n
s
f
e
c
t
i
o
n
 
e
f
f
i
c
i
e
n
c
y
 
(
R
L
U
/
m
g
 
p
r
o
t
e
i
n
)
0 0.2
mole fraction DOPC sM (×10–3 e/Å2)
0.4 0.6 0.8 5 10 15 20
DOTAP/DOPC
DOSPA/DOPC
DMRIE/DOPC
DOTAP/DOPC
DOSPA/DOPC
DMRIE/DOPC
(a) (b)
Lα
c
Lα
c
Figure 11. Plots of TE measurements (relative light units normalized to milligrams of protein) in
DOPC containing LC
a CL–DNA complexes. The data are for two univalent cationic lipids (DOTAP
and DMRIE) and the multivalent (5
C) cationic lipid DOSPA. (a) TE versus mole fraction of
DOPC. (b) Same data as in (a), where the TE is plotted versus the membrane charge density of the
CL vectors (sM, cationic charge per unit area). Adapted from Lin et al. (2003).
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Phil. Trans. R. Soc. A (2006)AnlZ72 A ˚2, rDOTAPZ1, rMVL2Z1.05G0.05, rMVL3Z1.30G0.05, rMVL5Z2.3G
0.1, rTMVL5Z2.5G0.1, ZDOTAPZ1, ZMVL2Z2.0G0.1, ZMVL3 Z2.5G0.1 and
ZMVL5ZZTMVL5Z4.5G0.1 Once again, as we found previously (ﬁgure 11b), a
notable simpliﬁcation takes place and all the data points merge onto a single
curve. Together with the data of ﬁgure 11b, we observe that for all lamellar LC
a
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Figure 12. Multivalent cationic lipids speciﬁcally synthesized for systematic variation of lipid
headgroup size and charge.
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Figure 13. Plots of TE measurements (relative light units normalized to milligrams of protein)
versus the membrane charge density (sM) in ﬁve DOPC containing LC
a CL–DNA complexes and
contrasted against DOPE containing HC
II CL–DNA complexes (open circle). The LC
a TE data are for
four multivalent cationic lipids (MVL2, MVL3, MVL5 and TMVL5) and the univalent DOTAP.
All LC
a complexes follow a universal curve (consistent with the data of ﬁgure 11b) for TE versus sM
with a central part that exhibits a bell curve (solid line). Adapted from Ahmad et al. (2005).
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resulting curve (ﬁgure 13) describes a Gaussian TEZTE0CA exp [(sMKsM
  )/ w]
2,
with TE0ZK(2.4G0.4)!10
7 RLU mg
K1 protein, AZ(9.4G0.6)!10
8 RLU mg
K1
proteinandwZ5.8G0.5!10
K3(e A ˚K2).Fortheoptimalchargedensity,theﬁtgives
sM
  Z17.0G0.1!10
K3 (e A ˚K2)( Ahmad et al. 2005). Signiﬁcantly, we note that
the TE of DOTAP/DOPE containing complexes, which exhibit the HC
II phase in
the low sM region labelled regime I in ﬁgure 13, is independent of sM.
Figure 14 shows that the confocal microscopic images of cells interacting
with highly transfectant (sMz0.012 e A ˚K2)L C
a complexes show a completely
different path of cell entry and subsequent DNA release than high-transfecting
HC
II complexes (ﬁgure 9) and low-transfecting LC
a complexes at low sM (ﬁgure 10,
sMz0.003 e A ˚K2). Intact complexes (yellow) were found inside the cell, but more
revealing, condensed reporter genes (green-DNA) successfully transferred into
Figure 14. Laser-scanning confocal microscopy image of high-transfecting LC
a CL–DNA complexes
interacting with a mouse ﬁbroblast L-cell, ﬁxed after 6 h (18 wt% DOPC/82 wt% DOTAP,
DOTAP/DNA charge ratioZ2.8). DNA is labelled green and lipid is labelled red. In contrast to
ﬁgure 9 (showing high-transfecting HC
II CL–DNA complexes), no fusion with the plasma membrane
is seen implying that the complexes enter cells through endocytosis. Inside the cell, both lipid-free
condensed DNA (green) and intact complexes (yellow) are found (both are circled in the x–y plane
with corresponding arrows in the x–z and y–z planes). This indicates that if LC
a complexes are
prepared at high charge density (sMz0.012 e A ˚K2, where high TE is observed as shown in ﬁgures
11 and 13), they will release DNA inside cells. Adapted from Lin et al. (2003).
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complexes entering cells through endocytosis. Since endosomes contain no DNA-
condensing agent, these condensed aggregates reside in the cytoplasm. The
presence of lipid-released DNA in the cytoplasm after endocytic uptake of these
complexes implies fusion between CL–DNA lipids and endosomal membranes,
which enables escape from the endosomes.
The combined confocal microscopy, enabling visualization of the interactions
betweencomplexesandcells,andTEdataleadtoamodelofcellularentryviaLC
a CL
carriers (Lin et al.2 0 0 3 ; Ahmad et al.2 0 0 5 ). The universal TE curve of the lamellar
complexes shown in ﬁgure 13 may be divided into three well-deﬁned regimes, which
correspond to distinct complex–cell interactions (Ahmad et al.2 0 0 5 ).
Figure 15 shows a model of cellular uptake of LC
a complexes. The initial cell
attachment is mediated by electrostatics (ﬁgure 15a) followed by cellular uptake
of the complex via endocytosis (ﬁgure 15b). At low sM!s 
M (regime I), where TE
increases exponentially with sM over three orders of magnitude, transfection is
limited by endosomal escape (ﬁgure 15c,d) as previously described (ﬁgure 11b
and Lin et al. 2003). At high sM, in regimes II and III, complexes are able to
overcome this barrier by fusing with the endosomal membrane and releasing
smaller complexes into the cytoplasm (ﬁgure 15e). Different behaviour is
observed at sMOs 
M in regime III, where TE decreases with sM. We hypothesize
that transfection is limited by complex dissociation in the cytoplasm owing to the
strong electrostatic interaction between the high sM lipid bilayer and the DNA,
and by the release of DNA from aggregates containing cationic cellular
components (ﬁgure 15g), both of which are observed in confocal microscopy
(ﬁgure 14). The optimal TE in regime II reﬂects the compromise between
cell-p-membrane CL-DNA
out
in
regime II: sªs0
regime III: s>s0
regime I: s<s0
high sM
low sM
(d)
(a)
(b)
(c)
(e)
(g)
(f)
Figure 15. Model of cellular uptake of LC
a complexes. (a) Cationic complexes attach to cells owing
to favourable electrostatic interactions and (b, c) enter through endocytosis. (d) Low membrane
charge density (sM) complexes remain trapped in endosomes. (e) High sM complexes escape the
endosome through fusion. (f, g) The released smaller complexes are unable to completely dissociate
their DNA content (with the effect being more pronounced in regime III at higher sM) and some of
the released DNA are further trapped in aggregates with oppositely charged cellular components.
Adapted from Ahmad et al. (2005).
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dissociation of complexes in the cytoplasm requires low sM. Future strategies for
optimization must decouple the opposing requirements.
5. Concluding remarks and future studies
We have seen that the membrane charge density (sM) is a universal chemical
parameter for transfection by lamellar LC
a CL–DNA complexes. The newly
synthesized series of cationic lipids, with multivalent headgroups, has allowed us
to test and verify the generality of the hypothesis concerning sM. Furthermore,
we found that the TE of HC
II complexes is independent of sM, with the high TE
probably related to the observed rapid fusion (ﬁgure 9) between the membranes
of complexes containing DOPE and the membranes of the plasma membrane
(which might have occurred during endocytosis; Lin et al. 2003). One mechanism
that may be responsible for the rapid fusion is the fact that the outermost lipid
monolayer, which must cover the HC
II complex owing to the hydrophobic effect, is
at an opposite curvature to that of the preferred negative curvature of the lipids
coating DNA inside the complex (ﬁgure 8). This elastically frustrated state of the
outer monolayer, which is independent of sM, would then drive rapid fusion with
the plasma or endosomal membrane leading to release of a layer of DNA and a
smaller HC
II complex within the cell. This process would then repeat itself until all
the DNA are released from the complex. By comparison, the bilayers of lamellar
LC
a complexes are inherently more stable and the onion-like (lipid bilayer/DNA
monolayer) complex is expected to peel, layer-by-layer, much more slowly
through interactions of the cationic membranes with anionic components of the
cell such as the predominantly anionic actin and microtubule (MT) cytoskeletal
ﬁlaments (Wong et al. 2000; Raviv et al. 2005).
The in vitro studies described in this paper are expected to be relevant to TE
optimization in ex vivo cell transfection, where cells are removed and returned to
patients after transfection. Our studies, which have a goal of elucidating
mechanisms underlying TE in continuous (dividing) cell lines, should aid clinical
efforts to develop efﬁcient CL vector cancer vaccines in ex vivo applications and
possibly in vivo applications in local tumours (Rinehart et al. 1997; Stopeck et al.
1998; Clark & Hersh 1999). The vaccines are intended to induce transient
expression of genes coding for immuno-stimulatory proteins in dividing cancer
cells, where the nuclear membrane, which dissolves during mitosis, is not
considered a barrier to the expression of DNA.
Future experiments, where the bending modulus of the cationic membrane will
be varied (Saﬁnya et al. 1989), will test the hypothesis that softening of the
membraneshouldenhanceTEowingtoincreasedprobabilityoffusionofCL–DNA
complexes with endosomal membranes facilitating delivery of complexes into
the cytoplasm. In a subtler manner, the Gaussian elastic modulus should also
affect TE. To elucidate the role of Gaussian modulus, we intend on studying
CL–DNA complexes containing neutral lipids, which by themselves exhibit the
bicontinuous cubic phase (membranes with negative surface curvature) owing
to a positive Gaussian modulus. As neutral lipids with a negative spontaneous
curvature result in the inverse hexagonal HC
II nanostructure, CL–DNA
complexes containing membranes with a positive Gaussian modulus should
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show enhanced TE owing to their potential tendency to form energetically
favoured pores (with negative curvature) with endosomal membranes releasing
DNA into the cytoplasm.
Future experiments will also be conducted using surface-functionalized
CL–DNA complexes designed to target cell surface receptors and the nuclear
membrane (Jans et al. 1998; Cartier & Reszka 2002; Escriou et al. 2003; Hebert
2003). This involves using speciﬁcally synthesized peptide-spacer lipid molecules
with deﬁned peptide sequences and poly(ethylene glycol) spacers of varying
lengths. The experiments with peptides containing the RGD (arginine-glycine-
aspartic acid) and SV40 nuclear localization sequences (NLS) should serve as
models for transfection in slowly or non-dividing cells (which would require the
NLS-sequence), and for complexes to be used in systemic in vivo delivery
applications, where the RGD sequence would attach complexes to RGD-speciﬁc
surface receptors cells.
(a) Two state bionanotubes with open and closed ends for gene delivery
The HC
II structure may be viewed as an ordered assembly of nanometre-scale
lipid tubules each encapsulating DNA molecules. This raises the question of
whether it is possible to develop isolated nanotubes for nucleic acid (genes, gene
silencing short interfering RNAs), peptide (Subramanian et al. 2000) and
chemical delivery applications. This would lead to the unprecedented ability to
manipulate the carrier (for example, opening and closing the ends of a tube in
response to an external parameter) at the nanometre scale.
The interactions between MTs, which are nanotubes consisting of tubulin
polymers derived from the eukaryotic cell with a diameter of the order of 25 nm
(Needleman et al. 2004a,b, 2005), and CLs were recently found to result, under
the appropriate conditions, in the spontaneous formation of lipid–protein
nanotubes (LPNs) with the MT coated by a lipid bilayer under the appropriate
conditions (Raviv et al. 2005). The LPNs may be viewed as a new paradigm for
lipid self-assembly leading to nanotube formation in mixed charged systems, with
the MT constituting the oppositely charged anionic macromolecule. It was found
that it is possible to switch between two states of the nanotubes, with either open
or closed ends with lipid caps, by controlling the cationic lipid/tubulin
stoichiometry and the ratio of the macromolecular areas of lipid to MT,
ALipid/AMicrotubule. Thus, the LPNs are model nanotubes for applications
involving controlled chemical and gene encapsulation, and release.
Taxol-stabilized MTs were mixed with CLs composed of cationic DOTAP and
DOPC as a function of M
CZNLC/(NLoCNLC), the mole fraction of cationic
lipid (NLC and NLo are the numbers of cationic and neutral lipids, respectively),
and RC/KZNLC/Nt, the relative cationic lipid/tubulin stoichiometry (Nt is the
number of tubulin dimers with RC/KZ40 near the isoelectric point of the
complex). For M
CO0.1, the CLs are observed to spread and coat the MT,
producing LPN as seen by transmission electron microscopy (TEM) shown in
ﬁgure 16.A tM
CZ0.5, the lipid coverage on the MT is observed to increase as
RC/K increases from partial lipid coating at RC/KZ40 (ﬁgure 16b, the uncoated
part of the MT is clearly visible on the left side) to full coverage at RC/KZ80
(ﬁgure 16c). Most interestingly, further increases in RC/K (in the excess CL
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RC/KZ120). Figure 16e shows another example of an LPN with closed ends at a
higher membrane charge density (M
CZ0.8) for RC/KZ80.
The TEM images show that the LPN contains an outer third layer (see, the
cross-section view of the LPN in ﬁgure 16a), which is also substantiated in X-ray
diffraction experiments (Raviv et al. 2005). The rather remarkable architecture
of the LPN is shown in the cartoon of ﬁgure 17 with the cylindrical lipid bilayer
sandwiched between the MT and a controllable partial outer layer of tubulin
oligomer. The ﬁgure also shows that the LPNs exist in two states and may
(b)( c)
100 nm
(e)
(a)
(d)
Figure 16. TEM images of the LPNs at different M
C (mole fraction of cationic lipid) and RC/KZ
NLC/Nt (cationic lipid/tubulin stoichiometric ratio giving the overall charge of the LPN; RC/KZ
40 is the isoelectric point). The LPN spontaneously forms when CLs with M
CO0.1 are mixed with
microtubules (MTs). (a) Cross-section of an LPN. (b, c) Side views of two LPNs with M
CZ0.5
and RC/KZ40, where the partially uncoated MT on the left side in (b) is visible, and M
CZ0.5 and
RC/KZ80, where the MT is fully coated but the ends remain open (c). (d, e) Side views of two
LPNs with M
CZ0.5 and RC/KZ120 (d), and M
CZ0.8, RC/KZ80 (e), where the LPNs exhibit
closed ends consisting of lipid end-caps. The cationic lipid/tubulin stoichiometry and the ratio of
the macromolecular areas of the lipid to the microtubule ALipid/AMicrotubule control the open/closed
states of the LPN. Adapted from Raviv et al. (2005).
Figure 17. Cartoon of the LPNs with open (middle) and closed ends with lipid caps (left), which
form the basis of controlled nanotubes for chemical encapsulation and release as described in the
text. Right shows a cross-section and a blow up of the MT–lipid bilayer–tubulin oligomer wall.
Redrawn from Raviv et al. (2005).
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encapsulation and/or release of chemicals and genes. Using the LPNs in gene
delivery applications will require further developments to replace the MT
component with a synthetic analogue.
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Discussion
A. S. MATHARU (Department of Chemistry, University of York, UK). How do the
cationic liposomes carrying DNA interact or cross cytoskeletal proteins once
endocytosis has occurred?
C.R.SAFINYA.Afterendocytosis,cationicliposome(CL)–DNAcomplexeswilltend
to interact with the oppositely charged biomolecules that they encounter. In
particular, positively charged CL–DNA complexes will interact with the
cytoskeletal ﬁlamentous proteins. These include ﬁlamentous-actin, microtubules
and intermediate ﬁlaments. In fact, the interactions may help to destabilize
CL–DNA complexes, which would lead to the release of DNA (a desirable result,
sincefreeDNAcanbetranscribedwiththeresultingRNAtranslatedintoprotein).
M.-H. LI (Institut Curie, France). Cationic lipids can also form vesicles, where a
large volume is available inside. Do you think vesicles would be another good
way for gene delivery, using this large volume to encapsulate the DNA?
C. R. SAFINYA. In fact, nearly 30 years ago, the ﬁrst synthetic carriers of DNA
were either neutral or negatively charged vesicles. These DNA carriers were
developed soon after Bangham discovered vesicles. However, such vesicle–DNA
complexes are not very efﬁcient in delivering DNA, because all the animal cells
are negatively charged and so the electrostatic interactions are not favourable.
Hence, researchers switched to cationic liposomes in 1987 to enhance their
electrostatic interactions with cells. However, it turns out that under equilibrium
conditions, when DNA is mixed with the so-called cationic giant vesicles, the
result is the spontaneous formation of self-assembled structures. To date, three
structures have been identiﬁed unambiguously. These include the lamellar LaC
phase, with alternating lipid bilayers and DNA monolayers (Ra ¨dler et al. 1997),
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Phil. Trans. R. Soc. A (2006)an inverse hexagonal HIIC phase, where DNA is encapsulated within inverse
micellar tubules (Koltover et al. 1998), and the recently discovered hexagonal
HIC phase, where rod-like micelles arranged on a hexagonal lattice are
surrounded by DNA, which ﬁlls the interstices with honeycomb symmetry
(Ewert et al. 2006).
V. PERCEC (Department of Chemistry, University of Pennsylvania, USA). You
have mentioned that the driving force for the self-assembly of DNA with lipids is
provided by the entropy gain provided by the release of counter-ions. Is any
molecular weight dependence observed between the molar mass of DNA and the
lipid aggregate and the stability of their complex?
C. R. SAFINYA. I have to assume that the most stable complexes are those
prepared near their isoelectric point, where the total number of negative
phosphate groups from the DNA backbone equals the cationic groups of the
cationic lipid headgroup. This is because the isoelectric point would correspond
to the point where most counter-ions are released and hence the entropy gain is
maximal. From the isoelectric point of the CL–DNA complex, one may readily
determine the ratio of the DNA and cationic lipid molecular weights (and
determine, for example, what molecular weight of DNA gives rise to the most
stable CL–DNA complex for a given amount of cationic lipid).
J. SEDDON (Department of Chemistry, Imperial College London, UK). Does the
HIIC DNA complex pick up a new outer monolayer from the inner monolayer at
the plasma membrane on crossing it into the cytoplasm?
C. R. SAFINYA. In fact one has to assume that the hydrophobic interaction will
require that the HIIC complex always has an outer monolayer (which has a
positive curvature). This monolayer can be either from within the complex itself
or from the plasma membrane or the endosomal membrane after the complex has
interacted with the cell. A thorough discussion of this issue may be found
elsewhere (Lin et al. 2003; Ewert et al. 2005a).
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